Security key
53566P109
Lineage Cell Therapeutics, Inc. - Common shares (LCTX)
CUSIP: 53566P109
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common shares
- Shares outstanding
- 250,425,788
- Total 13F shares
- 97,785,816
- Share change
- -11,557,679
- Total reported value
- $88,366,897
- Put/Call ratio
- 0%
- Price per share
- $0.91
- Number of holders
- 128
- Value change
- -$8,826,258
- Number of buys
- 58
- Number of sells
- 66
Report period
Q2 2025
Institutions
128
Top holders
10
LCTX full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Lineage Cell Therapeutics, Inc. SEC filings
Lineage Cell Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 53566P109
Recent filing periods:
Top shareholders of LCTX - Lineage Cell Therapeutics, Inc. - Common shares (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
13D/G
|
Company |
1%
from 13D/G
|
11,453,305
|
$5,172,314 | — | 31 Mar 2025 | |
| BROADWOOD CAPITAL INC |
13F
|
Company |
20%
|
49,560,992
|
$22,381,744 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.6%
|
8,919,043
|
$4,031,408 | — | 31 Mar 2025 | |
| Defender Capital, LLC. |
13F
|
Company |
2.5%
|
6,310,873
|
$3,155,437 | — | 31 Mar 2025 | |
| RAFFLES ASSOCIATES LP |
13F
|
Company |
2.3%
|
5,642,088
|
$2,547,967 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
4,485,586
|
$2,026,042 | — | 31 Mar 2025 | |
| COMERICA BANK |
13F
|
Company |
1.2%
|
3,000,000
|
$1,354,800 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.1%
|
2,650,186
|
$1,196,824 | — | 31 Mar 2025 | |
| DAFNA Capital Management LLC |
13F
|
Company |
1%
|
2,511,374
|
$1,134,136 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.91%
|
2,291,381
|
$1,034,788 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.61%
|
1,539,586
|
$695,276 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.39%
|
968,781
|
$437,503 | — | 31 Mar 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.37%
|
936,892
|
$423,000 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.24%
|
605,044
|
$273,236 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.21%
|
527,770
|
$237,000 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.21%
|
515,445
|
$232,775 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.2%
|
503,193
|
$227,242 | — | 31 Mar 2025 | |
| RED CRANE WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
495,996
|
$223,992 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.19%
|
480,423
|
$216,959 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.14%
|
357,772
|
$161,570 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.14%
|
350,103
|
$158,106 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
337,827
|
$152,563 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.11%
|
263,917
|
$119,291 | — | 31 Mar 2025 | |
| COOKSON PEIRCE & CO INC |
13F
|
Company |
0.1%
|
250,000
|
$112,900 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.09%
|
236,109
|
$106,627 | — | 31 Mar 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.09%
|
223,364
|
$100,871 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.08%
|
208,918
|
$94,000 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.08%
|
204,106
|
$92,174 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.08%
|
201,447
|
$91,049 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.08%
|
195,045
|
$88,082 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.07%
|
174,702
|
$78,616 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
167,900
|
$75,824 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
160,973
|
$72,600 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.05%
|
128,102
|
$57,851 | — | 31 Mar 2025 | |
| ORG Partners LLC |
13F
|
Company |
0.05%
|
115,400
|
$47,428 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
113,446
|
$51,232 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.04%
|
104,061
|
$46,994 | — | 31 Mar 2025 | |
| Williams Jones Wealth Management, LLC. |
13F
|
Company |
0.04%
|
101,300
|
$45,747 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.04%
|
97,252
|
$43,828 | — | 31 Mar 2025 | |
| Corebridge Financial, Inc. |
13F
|
Company |
0.04%
|
87,955
|
$39,720 | — | 31 Mar 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.03%
|
72,398
|
$33,000 | — | 31 Mar 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
68,068
|
$30,740 | — | 31 Mar 2025 | |
| MAI Capital Management |
13F
|
Company |
0.03%
|
64,391
|
$29,079 | — | 31 Mar 2025 | |
| SG Americas Securities, LLC |
13F
|
Company |
0.03%
|
63,159
|
$29,000 | — | 31 Mar 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.02%
|
58,708
|
$27,000 | — | 31 Mar 2025 | |
| Invesco Ltd. |
13F
|
Company |
0.02%
|
58,038
|
$26,210 | — | 31 Mar 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.02%
|
57,706
|
$26,060 | — | 31 Mar 2025 | |
| Fort Sheridan Advisors LLC |
13F
|
Company |
0.02%
|
55,177
|
$24,918 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.02%
|
50,922
|
$22,996 | — | 31 Mar 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
48,372
|
$21,845 | — | 31 Mar 2025 |
Institutional Holders of Lineage Cell Therapeutics, Inc. - Common shares (LCTX) as of Q2 2025
As of 30 Jun 2025,
Lineage Cell Therapeutics, Inc. - Common shares (LCTX) was held by
128 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
97,785,816 shares.
The largest 10 holders included
BROADWOOD CAPITAL INC, VANGUARD GROUP INC, Defender Capital, LLC., RAFFLES ASSOCIATES LP, COMERICA BANK, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock, Inc., RENAISSANCE TECHNOLOGIES LLC, and JANE STREET GROUP, LLC.
This page lists
128
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
126
Q2 2025 holders
128
Holder diff
2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.